Wafik El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in cancer personalized medicine, shared a post on LinkedIn:
“Another outstanding WIN Consortium in cancer personalized medicine, Molecular Tumor Board today, with helpful discussions by disease experts and precision oncology experts. Challenging endometrial, breast cancer, and GBM cases with discussion of Pol-delta variants, MDM4 amp, and other targets. Great insights and shared knowledge today.”
You can find more posts featuring Wafik S. El-Deiry in OncoDaily.
